Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States 2004–2014: A Generalized Additive Modeling Approach

OBJECTIVES: To predict healthcare cost trajectories for patients with newly diagnosed acute myeloid leukemia (AML) receiving allogeneic hematopoietic cell transplantation (alloHCT), as a function of days since chemotherapy initiation, days relative to alloHCT and days before death or last date of in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacoeconomics
Main Authors: Mau, Lih-Wen, Preussler, Jaime M., Burns, Linda J., Leppke, Susan, Majhail, Navneet S., Meyer, Christa L., Mupfudze, Tatenda, Saber, Wael, Steinert, Patricia, Vanness, David J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7194165/
https://ncbi.nlm.nih.gov/pubmed/32128725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-020-00891-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados